AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has informed the stock exchanges that the trading window for its securities will remain closed for insiders, designated persons, and their immediate relatives starting January 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ended December 31, 2025. The closure is in compliance with SEBI's Insider Trading Regulations, 2015. The company has already notified its designated persons about this restriction, prohibiting any buying, selling, or pledging of shares during the closure period. The board meeting date to approve the Q3 FY26 results will be communicated separately in due course.
This is a routine, mandatory compliance filing ahead of upcoming quarterly results and is not material to the stock price. Investors should watch for the upcoming Q3 FY26 results announcement, which may move the stock, but this intimation itself carries no direct trading signal.